NCT02086006View on ClinicalTrials.gov

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

October 31, 2016

Study Completion Date

April 30, 2017

Conditions
Coronary Artery Disease
Interventions
DEVICE

DESolve Novolimus Eluting Bioresorbable Coronary Scaffold

Trial Locations (3)

1023

Auckland City Hospital, Auckland

Mercy Angiography Unit, Auckland

2020

AZ Middelheim Hospital, Antwerp

Sponsors
All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

NCT02086006 - Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial | Biotech Hunter | Biotech Hunter